Distribution patterns of intramyocellular and extramyocellular fat by magnetic resonance imaging in subjects with diabetes, prediabetes and normoglycaemic controls

Aim To evaluate the distribution of intramyocellular lipids (IMCLs) and extramyocellular lipids (EMCLs) as well as total fat content in abdominal skeletal muscle by magnetic resonance imaging (MRI) using a dedicated segmentation algorithm in subjects with type 2 diabetes (T2D), prediabetes and normo...

Full description

Saved in:
Bibliographic Details
Published inDiabetes, obesity & metabolism Vol. 23; no. 8; pp. 1868 - 1878
Main Authors Kiefer, Lena S., Fabian, Jana, Rospleszcz, Susanne, Lorbeer, Roberto, Machann, Jürgen, Kraus, Mareen S., Roemer, Frank, Rathmann, Wolfgang, Meisinger, Christa, Heier, Margit, Nikolaou, Konstantin, Peters, Annette, Storz, Corinna, Diallo, Thierno D., Schlett, Christopher L., Bamberg, Fabian
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2021
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1462-8902
1463-1326
1463-1326
DOI10.1111/dom.14413

Cover

Loading…
Abstract Aim To evaluate the distribution of intramyocellular lipids (IMCLs) and extramyocellular lipids (EMCLs) as well as total fat content in abdominal skeletal muscle by magnetic resonance imaging (MRI) using a dedicated segmentation algorithm in subjects with type 2 diabetes (T2D), prediabetes and normoglycaemic controls. Materials and Methods Subjects from a population‐based cohort were classified with T2D, prediabetes or as normoglycaemic controls. Total myosteatosis, IMCLs and EMCLs were quantified by multiecho Dixon MRI as proton‐density fat‐fraction (in %) in abdominal skeletal muscle. Results Among 337 included subjects (median age 56.0 [IQR: 49.0‐64.0] years, 56.4% males, median body mass index [BMI]: 27.2 kg/m2), 129 (38.3%) were classified with an impaired glucose metabolism (T2D: 49 [14.5%]; prediabetes: 80 [23.7%]). IMCLs were significantly higher than EMCLs in subjects without obesity (5.7% [IQR: 4.8%‐7.0%] vs. 4.1% [IQR: 2.7%‐5.8%], P < .001), whereas the amounts of IMCLs and EMCLs were shown to be equal and significantly higher in subjects with obesity (both 6.7%, P < .001). Subjects with prediabetes and T2D had significantly higher amounts of IMCLs and EMCLs compared with normoglycaemic controls (P < .001). In univariable analysis, prediabetes and T2D were significantly associated with both IMCLs (prediabetes: β: 0.76, 95% CI: 0.28‐1.24, P = .002; T2D: β: 1.56, 95% CI: 0.66‐2.47, P < .001) and EMCLs (prediabetes: β: 1.54, 95% CI: 0.56‐2.51, P = .002; T2D: β: 2.15, 95% CI: 1.33‐2.96, P < .001). After adjustment for age and gender, the association of IMCLs with prediabetes attenuated (P = 0.06), whereas for T2D, both IMCLs and EMCLs remained significantly and positively associated (P < .02). Conclusion There are significant differences in the amount and distribution ratio of IMCLs and EMCLs between subjects with T2D, prediabetes and normoglycaemic controls. Therefore, these patterns of intramuscular fat distribution by MRI might serve as imaging biomarkers in both normal and impaired glucose metabolism.
AbstractList Aim To evaluate the distribution of intramyocellular lipids (IMCLs) and extramyocellular lipids (EMCLs) as well as total fat content in abdominal skeletal muscle by magnetic resonance imaging (MRI) using a dedicated segmentation algorithm in subjects with type 2 diabetes (T2D), prediabetes and normoglycaemic controls. Materials and Methods Subjects from a population‐based cohort were classified with T2D, prediabetes or as normoglycaemic controls. Total myosteatosis, IMCLs and EMCLs were quantified by multiecho Dixon MRI as proton‐density fat‐fraction (in %) in abdominal skeletal muscle. Results Among 337 included subjects (median age 56.0 [IQR: 49.0‐64.0] years, 56.4% males, median body mass index [BMI]: 27.2 kg/m2), 129 (38.3%) were classified with an impaired glucose metabolism (T2D: 49 [14.5%]; prediabetes: 80 [23.7%]). IMCLs were significantly higher than EMCLs in subjects without obesity (5.7% [IQR: 4.8%‐7.0%] vs. 4.1% [IQR: 2.7%‐5.8%], P < .001), whereas the amounts of IMCLs and EMCLs were shown to be equal and significantly higher in subjects with obesity (both 6.7%, P < .001). Subjects with prediabetes and T2D had significantly higher amounts of IMCLs and EMCLs compared with normoglycaemic controls (P < .001). In univariable analysis, prediabetes and T2D were significantly associated with both IMCLs (prediabetes: β: 0.76, 95% CI: 0.28‐1.24, P = .002; T2D: β: 1.56, 95% CI: 0.66‐2.47, P < .001) and EMCLs (prediabetes: β: 1.54, 95% CI: 0.56‐2.51, P = .002; T2D: β: 2.15, 95% CI: 1.33‐2.96, P < .001). After adjustment for age and gender, the association of IMCLs with prediabetes attenuated (P = 0.06), whereas for T2D, both IMCLs and EMCLs remained significantly and positively associated (P < .02). Conclusion There are significant differences in the amount and distribution ratio of IMCLs and EMCLs between subjects with T2D, prediabetes and normoglycaemic controls. Therefore, these patterns of intramuscular fat distribution by MRI might serve as imaging biomarkers in both normal and impaired glucose metabolism.
To evaluate the distribution of intramyocellular lipids (IMCLs) and extramyocellular lipids (EMCLs) as well as total fat content in abdominal skeletal muscle by magnetic resonance imaging (MRI) using a dedicated segmentation algorithm in subjects with type 2 diabetes (T2D), prediabetes and normoglycaemic controls. Subjects from a population-based cohort were classified with T2D, prediabetes or as normoglycaemic controls. Total myosteatosis, IMCLs and EMCLs were quantified by multiecho Dixon MRI as proton-density fat-fraction (in %) in abdominal skeletal muscle. Among 337 included subjects (median age 56.0 [IQR: 49.0-64.0] years, 56.4% males, median body mass index [BMI]: 27.2 kg/m ), 129 (38.3%) were classified with an impaired glucose metabolism (T2D: 49 [14.5%]; prediabetes: 80 [23.7%]). IMCLs were significantly higher than EMCLs in subjects without obesity (5.7% [IQR: 4.8%-7.0%] vs. 4.1% [IQR: 2.7%-5.8%], P < .001), whereas the amounts of IMCLs and EMCLs were shown to be equal and significantly higher in subjects with obesity (both 6.7%, P < .001). Subjects with prediabetes and T2D had significantly higher amounts of IMCLs and EMCLs compared with normoglycaemic controls (P < .001). In univariable analysis, prediabetes and T2D were significantly associated with both IMCLs (prediabetes: β: 0.76, 95% CI: 0.28-1.24, P = .002; T2D: β: 1.56, 95% CI: 0.66-2.47, P < .001) and EMCLs (prediabetes: β: 1.54, 95% CI: 0.56-2.51, P = .002; T2D: β: 2.15, 95% CI: 1.33-2.96, P < .001). After adjustment for age and gender, the association of IMCLs with prediabetes attenuated (P = 0.06), whereas for T2D, both IMCLs and EMCLs remained significantly and positively associated (P < .02). There are significant differences in the amount and distribution ratio of IMCLs and EMCLs between subjects with T2D, prediabetes and normoglycaemic controls. Therefore, these patterns of intramuscular fat distribution by MRI might serve as imaging biomarkers in both normal and impaired glucose metabolism.
To evaluate the distribution of intramyocellular lipids (IMCLs) and extramyocellular lipids (EMCLs) as well as total fat content in abdominal skeletal muscle by magnetic resonance imaging (MRI) using a dedicated segmentation algorithm in subjects with type 2 diabetes (T2D), prediabetes and normoglycaemic controls.AIMTo evaluate the distribution of intramyocellular lipids (IMCLs) and extramyocellular lipids (EMCLs) as well as total fat content in abdominal skeletal muscle by magnetic resonance imaging (MRI) using a dedicated segmentation algorithm in subjects with type 2 diabetes (T2D), prediabetes and normoglycaemic controls.Subjects from a population-based cohort were classified with T2D, prediabetes or as normoglycaemic controls. Total myosteatosis, IMCLs and EMCLs were quantified by multiecho Dixon MRI as proton-density fat-fraction (in %) in abdominal skeletal muscle.MATERIALS AND METHODSSubjects from a population-based cohort were classified with T2D, prediabetes or as normoglycaemic controls. Total myosteatosis, IMCLs and EMCLs were quantified by multiecho Dixon MRI as proton-density fat-fraction (in %) in abdominal skeletal muscle.Among 337 included subjects (median age 56.0 [IQR: 49.0-64.0] years, 56.4% males, median body mass index [BMI]: 27.2 kg/m2 ), 129 (38.3%) were classified with an impaired glucose metabolism (T2D: 49 [14.5%]; prediabetes: 80 [23.7%]). IMCLs were significantly higher than EMCLs in subjects without obesity (5.7% [IQR: 4.8%-7.0%] vs. 4.1% [IQR: 2.7%-5.8%], P < .001), whereas the amounts of IMCLs and EMCLs were shown to be equal and significantly higher in subjects with obesity (both 6.7%, P < .001). Subjects with prediabetes and T2D had significantly higher amounts of IMCLs and EMCLs compared with normoglycaemic controls (P < .001). In univariable analysis, prediabetes and T2D were significantly associated with both IMCLs (prediabetes: β: 0.76, 95% CI: 0.28-1.24, P = .002; T2D: β: 1.56, 95% CI: 0.66-2.47, P < .001) and EMCLs (prediabetes: β: 1.54, 95% CI: 0.56-2.51, P = .002; T2D: β: 2.15, 95% CI: 1.33-2.96, P < .001). After adjustment for age and gender, the association of IMCLs with prediabetes attenuated (P = 0.06), whereas for T2D, both IMCLs and EMCLs remained significantly and positively associated (P < .02).RESULTSAmong 337 included subjects (median age 56.0 [IQR: 49.0-64.0] years, 56.4% males, median body mass index [BMI]: 27.2 kg/m2 ), 129 (38.3%) were classified with an impaired glucose metabolism (T2D: 49 [14.5%]; prediabetes: 80 [23.7%]). IMCLs were significantly higher than EMCLs in subjects without obesity (5.7% [IQR: 4.8%-7.0%] vs. 4.1% [IQR: 2.7%-5.8%], P < .001), whereas the amounts of IMCLs and EMCLs were shown to be equal and significantly higher in subjects with obesity (both 6.7%, P < .001). Subjects with prediabetes and T2D had significantly higher amounts of IMCLs and EMCLs compared with normoglycaemic controls (P < .001). In univariable analysis, prediabetes and T2D were significantly associated with both IMCLs (prediabetes: β: 0.76, 95% CI: 0.28-1.24, P = .002; T2D: β: 1.56, 95% CI: 0.66-2.47, P < .001) and EMCLs (prediabetes: β: 1.54, 95% CI: 0.56-2.51, P = .002; T2D: β: 2.15, 95% CI: 1.33-2.96, P < .001). After adjustment for age and gender, the association of IMCLs with prediabetes attenuated (P = 0.06), whereas for T2D, both IMCLs and EMCLs remained significantly and positively associated (P < .02).There are significant differences in the amount and distribution ratio of IMCLs and EMCLs between subjects with T2D, prediabetes and normoglycaemic controls. Therefore, these patterns of intramuscular fat distribution by MRI might serve as imaging biomarkers in both normal and impaired glucose metabolism.CONCLUSIONThere are significant differences in the amount and distribution ratio of IMCLs and EMCLs between subjects with T2D, prediabetes and normoglycaemic controls. Therefore, these patterns of intramuscular fat distribution by MRI might serve as imaging biomarkers in both normal and impaired glucose metabolism.
AimTo evaluate the distribution of intramyocellular lipids (IMCLs) and extramyocellular lipids (EMCLs) as well as total fat content in abdominal skeletal muscle by magnetic resonance imaging (MRI) using a dedicated segmentation algorithm in subjects with type 2 diabetes (T2D), prediabetes and normoglycaemic controls.Materials and MethodsSubjects from a population‐based cohort were classified with T2D, prediabetes or as normoglycaemic controls. Total myosteatosis, IMCLs and EMCLs were quantified by multiecho Dixon MRI as proton‐density fat‐fraction (in %) in abdominal skeletal muscle.ResultsAmong 337 included subjects (median age 56.0 [IQR: 49.0‐64.0] years, 56.4% males, median body mass index [BMI]: 27.2 kg/m2), 129 (38.3%) were classified with an impaired glucose metabolism (T2D: 49 [14.5%]; prediabetes: 80 [23.7%]). IMCLs were significantly higher than EMCLs in subjects without obesity (5.7% [IQR: 4.8%‐7.0%] vs. 4.1% [IQR: 2.7%‐5.8%], P < .001), whereas the amounts of IMCLs and EMCLs were shown to be equal and significantly higher in subjects with obesity (both 6.7%, P < .001). Subjects with prediabetes and T2D had significantly higher amounts of IMCLs and EMCLs compared with normoglycaemic controls (P < .001). In univariable analysis, prediabetes and T2D were significantly associated with both IMCLs (prediabetes: β: 0.76, 95% CI: 0.28‐1.24, P = .002; T2D: β: 1.56, 95% CI: 0.66‐2.47, P < .001) and EMCLs (prediabetes: β: 1.54, 95% CI: 0.56‐2.51, P = .002; T2D: β: 2.15, 95% CI: 1.33‐2.96, P < .001). After adjustment for age and gender, the association of IMCLs with prediabetes attenuated (P = 0.06), whereas for T2D, both IMCLs and EMCLs remained significantly and positively associated (P < .02).ConclusionThere are significant differences in the amount and distribution ratio of IMCLs and EMCLs between subjects with T2D, prediabetes and normoglycaemic controls. Therefore, these patterns of intramuscular fat distribution by MRI might serve as imaging biomarkers in both normal and impaired glucose metabolism.
Author Rospleszcz, Susanne
Storz, Corinna
Fabian, Jana
Nikolaou, Konstantin
Peters, Annette
Diallo, Thierno D.
Roemer, Frank
Kraus, Mareen S.
Kiefer, Lena S.
Rathmann, Wolfgang
Lorbeer, Roberto
Meisinger, Christa
Schlett, Christopher L.
Bamberg, Fabian
Heier, Margit
Machann, Jürgen
Author_xml – sequence: 1
  givenname: Lena S.
  orcidid: 0000-0002-3999-559X
  surname: Kiefer
  fullname: Kiefer, Lena S.
  email: lena.kiefer@med.uni-tuebingen.de
  organization: University of Tuebingen
– sequence: 2
  givenname: Jana
  surname: Fabian
  fullname: Fabian, Jana
  organization: University of Tuebingen
– sequence: 3
  givenname: Susanne
  surname: Rospleszcz
  fullname: Rospleszcz, Susanne
  organization: Institute of Epidemiology, Helmholtz Zentrum München
– sequence: 4
  givenname: Roberto
  surname: Lorbeer
  fullname: Lorbeer, Roberto
  organization: German Centre for Cardiovascular Research (DZHK e.V.)
– sequence: 5
  givenname: Jürgen
  surname: Machann
  fullname: Machann, Jürgen
  organization: German Center for Diabetes Research (DZD)
– sequence: 6
  givenname: Mareen S.
  surname: Kraus
  fullname: Kraus, Mareen S.
  organization: University of Tuebingen
– sequence: 7
  givenname: Frank
  surname: Roemer
  fullname: Roemer, Frank
  organization: Boston University School of Medicine
– sequence: 8
  givenname: Wolfgang
  surname: Rathmann
  fullname: Rathmann, Wolfgang
  organization: Institute for Biometrics and Epidemiology
– sequence: 9
  givenname: Christa
  surname: Meisinger
  fullname: Meisinger, Christa
  organization: Independent Research Group Clinical Epidemiology, Helmholtz Zentrum München
– sequence: 10
  givenname: Margit
  surname: Heier
  fullname: Heier, Margit
  organization: University Hospital Augsburg
– sequence: 11
  givenname: Konstantin
  surname: Nikolaou
  fullname: Nikolaou, Konstantin
  organization: University of Tuebingen
– sequence: 12
  givenname: Annette
  surname: Peters
  fullname: Peters, Annette
  organization: German Center for Diabetes Research (DZD)
– sequence: 13
  givenname: Corinna
  surname: Storz
  fullname: Storz, Corinna
  organization: Medical Center, Faculty of Medicine, University of Freiburg
– sequence: 14
  givenname: Thierno D.
  surname: Diallo
  fullname: Diallo, Thierno D.
  organization: University Medical Center Freiburg, Faculty of Medicine, University of Freiburg
– sequence: 15
  givenname: Christopher L.
  surname: Schlett
  fullname: Schlett, Christopher L.
  organization: University Medical Center Freiburg, Faculty of Medicine, University of Freiburg
– sequence: 16
  givenname: Fabian
  surname: Bamberg
  fullname: Bamberg, Fabian
  organization: University Medical Center Freiburg, Faculty of Medicine, University of Freiburg
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33914415$$D View this record in MEDLINE/PubMed
BookMark eNp9kc9u1DAQxi1URP_AgRdAlriARFpPbO_GR9QCRWrVC5wj25ksXiX2YjsqeR5eFO9uy2Gldi6eGf3m03i-U3Lkg0dC3gI7hxIXXRjPQQjgL8gJiAWvgNeLo11eV41i9TE5TWnNGBO8Wb4ix5yrLS9PyN8rl3J0ZsoueLrROWP0iYaeOp-jHudgcRimQUeqfUfxz0Gz15mamY565TE7SyOm4LW3SF3pOb8qOjRNZo02J3rv8i_aOW0wY_pENxEfi526D3EMq2G2GseiZUNZIQzpNXnZ6yHhm4f3jPz8-uXH5XV1c_ft--Xnm8rypuGVWmjBegVWgBFaclA9k4pZvexZp7gydSOZRavMAqWxzKDCni2lBC07a4GfkQ973U0MvydMuR1d2v5UewxTamsJqgEQjSjo-wN0Haboy3aFkjWAXDZ1od49UJMZsWs3sRwlzu3j-QvwcQ_YGFKK2P9HgLVba9tibbuztrAXB6x1WW9tK5a44bmJezfg_LR0e3V3u5_4ByMtuLI
CitedBy_id crossref_primary_10_3389_fendo_2025_1520436
crossref_primary_10_1002_jcsm_13527
crossref_primary_10_1038_s41580_023_00680_1
crossref_primary_10_1016_j_aninu_2024_03_003
crossref_primary_10_3389_fnut_2022_807841
crossref_primary_10_1007_s00330_022_09035_4
crossref_primary_10_1016_j_cmet_2021_12_012
crossref_primary_10_3390_ijerph19074201
crossref_primary_10_1002_rco2_92
crossref_primary_10_1016_j_smhs_2022_08_001
crossref_primary_10_1002_jcsm_13192
crossref_primary_10_1097_RLI_0000000000000909
crossref_primary_10_1007_s00592_024_02440_9
crossref_primary_10_1016_j_pcd_2022_09_003
crossref_primary_10_1016_j_phrs_2024_107525
crossref_primary_10_23736_S2724_6507_21_03405_9
crossref_primary_10_1016_j_metabol_2024_156130
crossref_primary_10_1016_j_zemedi_2022_12_004
Cites_doi 10.1002/jmri.22036
10.1007/BF00399946
10.2337/diabetes.48.5.1113
10.1210/jc.2002-021674
10.2337/dc09-S302
10.1016/S0140-6736(63)91500-9
10.1055/s-2001-12407
10.2337/diabetes.55.01.06.db05-1286
10.1097/RLI.0b013e3181f10fe1
10.2337/diabetes.48.8.1600
10.1002/jmri.21754
10.1148/radiol.12120399
10.2337/diabetes.51.1.7
10.1172/JCI118160
10.1515/hmbci-2015-0045
10.2337/diabetes.49.5.677
10.2337/db16-0630
10.1016/S0026-0495(98)90287-6
10.1002/mrm.1910290203
10.1002/1522-2594(200102)45:2<179::AID-MRM1023>3.0.CO;2-D
10.1055/s-0042-104510
10.2337/diabetes.50.10.2337
10.1148/radiol.2015142272
ContentType Journal Article
Copyright 2021 The Authors. published by John Wiley & Sons Ltd.
2021 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2021 The Authors. published by John Wiley & Sons Ltd.
– notice: 2021 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
– notice: 2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
7T5
7TK
H94
K9.
7X8
DOI 10.1111/dom.14413
DatabaseName Wiley Online Library Open Access
CrossRef
PubMed
Immunology Abstracts
Neurosciences Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1463-1326
EndPage 1878
ExternalDocumentID 33914415
10_1111_dom_14413
DOM14413
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OC
24P
29F
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
ROL
RX1
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
NPM
7T5
7TK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
7X8
ID FETCH-LOGICAL-c3883-96a40f91c41b4a5319f0590ca7f0d939b2850cec9b6e5bc0be9ef07551a5dcc13
IEDL.DBID DR2
ISSN 1462-8902
1463-1326
IngestDate Fri Jul 11 16:19:12 EDT 2025
Fri Jul 25 07:59:18 EDT 2025
Thu Apr 03 06:59:22 EDT 2025
Tue Jul 01 01:03:27 EDT 2025
Thu Apr 24 23:01:25 EDT 2025
Wed Jan 22 16:28:40 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords body composition
cohort study
type 2 diabetes
Language English
License Attribution-NonCommercial-NoDerivs
2021 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3883-96a40f91c41b4a5319f0590ca7f0d939b2850cec9b6e5bc0be9ef07551a5dcc13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-3999-559X
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fdom.14413
PMID 33914415
PQID 2552115782
PQPubID 1006516
PageCount 11
ParticipantIDs proquest_miscellaneous_2519811484
proquest_journals_2552115782
pubmed_primary_33914415
crossref_primary_10_1111_dom_14413
crossref_citationtrail_10_1111_dom_14413
wiley_primary_10_1111_dom_14413_DOM14413
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2021
PublicationDateYYYYMMDD 2021-08-01
PublicationDate_xml – month: 08
  year: 2021
  text: August 2021
PublicationDecade 2020
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
– name: Oxford
PublicationTitle Diabetes, obesity & metabolism
PublicationTitleAlternate Diabetes Obes Metab
PublicationYear 2021
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References 1995; 96
2001; 50
2010; 31
1993; 29
2000; 49
2010
2002; 51
2006; 55
2017; 66
1999; 48
2013; 266
2016; 188
2006
2001; 45
1998; 47
2009; 29
2010; 45
1993; 36
1963; 281
2009; 32
2000
2015; 277
2018; 91
2013
2001; 33
2016; 26
2003; 88
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_17_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_13_1
Laurens C (e_1_2_7_27_1) 2016; 26
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_26_1
e_1_2_7_28_1
e_1_2_7_29_1
World Health Organization (e_1_2_7_18_1) 2006
Kiefer LS (e_1_2_7_16_1) 2018; 91
World Health Organization (e_1_2_7_19_1) 2000
e_1_2_7_25_1
e_1_2_7_24_1
e_1_2_7_22_1
e_1_2_7_21_1
e_1_2_7_20_1
World Health Organization (e_1_2_7_23_1) 2013
References_xml – volume: 29
  start-page: 1340
  year: 2009
  end-page: 1345
  article-title: Intermuscular adipose tissue (IMAT): association with other adipose tissue compartments and insulin sensitivity
  publication-title: J Magn Reson Imaging.
– volume: 31
  start-page: 430
  year: 2010
  end-page: 439
  article-title: Topography mapping of whole body adipose tissue using a fully automated and standardized procedure
  publication-title: J Magn Reson Imaging.
– start-page: 1
  year: 2006
  end-page: 50
– volume: 33
  start-page: 63
  year: 2001
  end-page: 66
  article-title: Utilisation of intramyocellular lipids (IMCLs) during exercise as assessed by proton magnetic resonance spectroscopy (1H‐MRS)
  publication-title: Horm Metab Res.
– volume: 91
  start-page: 1
  year: 2018
  end-page: 9
  article-title: Inter‐ and intraobserver variability of an anatomical landmark‐based, manual segmentation method by MRI for the assessment of skeletal muscle fat content and area in subjects from the general population
  publication-title: Br J Radiol.
– volume: 45
  start-page: 788
  year: 2010
  end-page: 794
  article-title: Quantitative analysis of adipose tissue in single transverse slices for estimation of volumes of relevant fat tissue compartments: a study in a large cohort of subjects at risk for type 2 diabetes by MRI with comparison to anthropometric data
  publication-title: Invest Radiol.
– volume: 188
  start-page: 652
  year: 2016
  end-page: 661
  article-title: Population‐based imaging and radiomics: rationale and perspective of the German National Cohort MRI Study
  publication-title: Rofo.
– volume: 45
  start-page: 179
  year: 2001
  end-page: 183
  article-title: Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H‐MRS study
  publication-title: Magn Reson Med.
– year: 2000
– volume: 32
  start-page: 157
  year: 2009
  end-page: 163
  article-title: Skeletal muscle insulin resistance is the primary defect in type 2 diabetes
  publication-title: Diabetes Care.
– start-page: 1
  year: 2013
  end-page: 40
– volume: 88
  start-page: 1785
  year: 2003
  end-page: 1791
  article-title: Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity
  publication-title: J Clin Endocrinol Metab.
– volume: 277
  start-page: 206
  year: 2015
  end-page: 220
  article-title: Whole‐body MR imaging in the German National Cohort: rationale, design, and technical background
  publication-title: Radiology.
– volume: 26
  start-page: 43
  year: 2016
  end-page: 52
  article-title: Intramyocellular fat storage in metabolic diseases
  publication-title: Horm Mol Biol Clin Investig.
– volume: 36
  start-page: 176
  year: 1993
  end-page: 182
  article-title: Pathogenesis of type 2 (non‐insulin‐dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle
  publication-title: Diabetologia.
– volume: 51
  start-page: 7
  year: 2002
  end-page: 18
  article-title: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes
  publication-title: Diabetes.
– year: 2010
– volume: 50
  start-page: 2337
  year: 2001
  end-page: 2343
  article-title: Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle
  publication-title: Diabetes.
– volume: 48
  start-page: 1113
  year: 1999
  end-page: 1119
  article-title: Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects
  publication-title: Diabetes.
– volume: 49
  start-page: 677
  year: 2000
  end-page: 683
  article-title: Fuel selection in human skeletal muscle in insulin resistance: a reexamination
  publication-title: Diabetes.
– volume: 48
  start-page: 1600
  year: 1999
  end-page: 1606
  article-title: Intramyocellular triglyceride content is a determinan of in vivo insulin resistance in humans
  publication-title: Diabetes.
– volume: 66
  start-page: 158
  year: 2017
  end-page: 169
  article-title: Subclinical disease burden as assessed by whole‐body MRI in subjects with prediabetes, subjects with diabetes, and normal control subjects from the general population: the KORA‐MRI study
  publication-title: Diabetes.
– volume: 281
  start-page: 785
  year: 1963
  end-page: 789
  article-title: The glucose fatty‐acid cycle ‐ its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
  publication-title: Lancet.
– volume: 55
  start-page: 136
  year: 2006
  end-page: 140
  article-title: Increased lipid availability impairs insulin‐stimulated ATP synthesis in human skeletal muscle
  publication-title: Diabetes
– volume: 266
  start-page: 555
  year: 2013
  end-page: 563
  article-title: Quantification of muscle fat in patients with low back pain: comparison of multi‐echo MR imaging with single‐voxel MR spectroscopy
  publication-title: Radiology.
– volume: 96
  start-page: 1261
  year: 1995
  end-page: 1268
  article-title: Effects of fat on glucose uptake and utilization in patients with non‐insulin‐dependent diabetes
  publication-title: J Clin Invest.
– volume: 47
  start-page: 1121
  year: 1998
  end-page: 1126
  article-title: Five‐hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat
  publication-title: Metabolism.
– volume: 29
  start-page: 158
  year: 1993
  end-page: 167
  article-title: Comparison of localized proton NMR signals Ff skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue
  publication-title: Magn Reson Med.
– ident: e_1_2_7_21_1
  doi: 10.1002/jmri.22036
– ident: e_1_2_7_2_1
  doi: 10.1007/BF00399946
– ident: e_1_2_7_13_1
  doi: 10.2337/diabetes.48.5.1113
– ident: e_1_2_7_26_1
  doi: 10.1210/jc.2002-021674
– volume: 91
  start-page: 1
  year: 2018
  ident: e_1_2_7_16_1
  article-title: Inter‐ and intraobserver variability of an anatomical landmark‐based, manual segmentation method by MRI for the assessment of skeletal muscle fat content and area in subjects from the general population
  publication-title: Br J Radiol.
– ident: e_1_2_7_7_1
  doi: 10.2337/dc09-S302
– ident: e_1_2_7_3_1
  doi: 10.1016/S0140-6736(63)91500-9
– volume-title: Obesity: Preventing and Managing the Global Epidemic
  year: 2000
  ident: e_1_2_7_19_1
– ident: e_1_2_7_25_1
  doi: 10.1055/s-2001-12407
– ident: e_1_2_7_5_1
  doi: 10.2337/diabetes.55.01.06.db05-1286
– start-page: 1
  volume-title: A Global Brief on Hypertension
  year: 2013
  ident: e_1_2_7_23_1
– ident: e_1_2_7_22_1
  doi: 10.1097/RLI.0b013e3181f10fe1
– ident: e_1_2_7_8_1
  doi: 10.2337/diabetes.48.8.1600
– ident: e_1_2_7_20_1
  doi: 10.1002/jmri.21754
– ident: e_1_2_7_15_1
  doi: 10.1148/radiol.12120399
– ident: e_1_2_7_4_1
  doi: 10.2337/diabetes.51.1.7
– ident: e_1_2_7_12_1
  doi: 10.1172/JCI118160
– ident: e_1_2_7_24_1
– volume: 26
  start-page: 43
  year: 2016
  ident: e_1_2_7_27_1
  article-title: Intramyocellular fat storage in metabolic diseases
  publication-title: Horm Mol Biol Clin Investig.
  doi: 10.1515/hmbci-2015-0045
– ident: e_1_2_7_6_1
  doi: 10.2337/diabetes.49.5.677
– ident: e_1_2_7_17_1
  doi: 10.2337/db16-0630
– ident: e_1_2_7_9_1
  doi: 10.1016/S0026-0495(98)90287-6
– ident: e_1_2_7_14_1
  doi: 10.1002/mrm.1910290203
– ident: e_1_2_7_10_1
  doi: 10.1002/1522-2594(200102)45:2<179::AID-MRM1023>3.0.CO;2-D
– start-page: 1
  volume-title: Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia
  year: 2006
  ident: e_1_2_7_18_1
– ident: e_1_2_7_29_1
  doi: 10.1055/s-0042-104510
– ident: e_1_2_7_11_1
  doi: 10.2337/diabetes.50.10.2337
– ident: e_1_2_7_28_1
  doi: 10.1148/radiol.2015142272
SSID ssj0004387
Score 2.438881
Snippet Aim To evaluate the distribution of intramyocellular lipids (IMCLs) and extramyocellular lipids (EMCLs) as well as total fat content in abdominal skeletal...
To evaluate the distribution of intramyocellular lipids (IMCLs) and extramyocellular lipids (EMCLs) as well as total fat content in abdominal skeletal muscle...
AimTo evaluate the distribution of intramyocellular lipids (IMCLs) and extramyocellular lipids (EMCLs) as well as total fat content in abdominal skeletal...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1868
SubjectTerms body composition
Body mass index
Cohort analysis
cohort study
Diabetes
Diabetes mellitus (non-insulin dependent)
Glucose metabolism
Image processing
Lipids
Magnetic resonance imaging
Metabolism
Musculoskeletal system
Obesity
Segmentation
Skeletal muscle
type 2 diabetes
Title Distribution patterns of intramyocellular and extramyocellular fat by magnetic resonance imaging in subjects with diabetes, prediabetes and normoglycaemic controls
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fdom.14413
https://www.ncbi.nlm.nih.gov/pubmed/33914415
https://www.proquest.com/docview/2552115782
https://www.proquest.com/docview/2519811484
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RDlUvLS19bKHIoB56aFAS28FWT4gtQkjboqpIHCpFfiIEm6zI7mH7d_ij9TgPun1IVW9xMrEdZ8aeGY-_AXjrM89zq3kSbA-fMCPSRKkiFPUBnryU2lr0Q04-FSfn7PSCX6zBh_4sTIsPMTjcUDLifI0CrnTzk5Dbeoo7kzFjbUYLxM0ff7mHjmI0JscLE0GQeIlRPBt9FM_w5upa9JuCuaqvxgXn-Al867vaxplc7y_met98_wXF8T-_ZQMed4ooOWw55ymsueoZPJx0W-2bcDdGSN0uGxaZRRjOqiG1J1foD54ua_T5YxArUZUlYY5fvenVnOglmarLCs9JkmDW1wju4cjVNGZGCvWQZqHRD9QQdAeT3g_8nsxuXV-ItVdBs64vb5ZGYSw_6eLrm-dwfvzx69FJ0mV0SAwVgiayUCz1MjMs00yh-Hs8_GrUgU-tpFLngqfGGakLx7VJtZPOB6WGZ4pbYzL6AtarunKvgJjAVqbQTBTUMsGFSrn1wfoTohA0y90I3vX_tjQd3Dlm3bgpe7MnDHoZB30EewPprMX4-BPRds8gZSfmTRnssRzRikQ-gt3hcRBQHGxVuXqBNJkUaHWyEbxsGWtohVIZDdrQ2cgef2--HH-exIvX_066BY9yjMCJ4YrbsD6_Xbg3QYWa6x14kLOznSgxPwARzBuV
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB5VRQIuqDy7UMAgDhyIlMR2aktcEKVaoFs4tFJvkZ9VpW6yanYP-3v4o8x4k8AKkLjFySSOPB575vM8AN7EIsrSW5mh7REz4VSeGVNh0x5S5KW23hMOOTutpufiy4W82IH3QyzMJj_ECLiRZKT1mgScAOnfpNy3czqapJK1twTq5eTQV4rvv6IieSqPh0sByrwmP569wY9nfHV7N_pDxdzWWNOWc7wH93pdkX3YMPc-7ITmAdye9afhD-HHEWW97QtWsUXKlNl0rI3siiDb-bolWJ78TJlpPMNlePtmNEtm12xuLhsKZWRoebeUfyOwq3kqXoTfYd3KElTTMUJs2QDVvmOLmzA00tcbVH7by-u1M-Ruz3oX-O4RnB9_Ovs4zfqiC5njSvFMV0bkURdOFFYYktBI8anOHMbca65tqWTugtO2CtK63AYdIuodsjDSO1fwx7DbtE3YB-aQ866yQlXcCyWVyaWPaKApVSlelGECb4fBr12fkZwKY1zXg2WCfKoTnybweiRdbNJw_I3oYOBg3UtiV6PJVFJCIVVO4NX4GGWIBts0oV0RTaEVGYZiAk82nB974VwnmxN_Nk2Ff3dfH32bpYun_0_6Eu5Mz2Yn9cnn06_P4G5JDjPJu_AAdpc3q_AcNZ6lfZEm9k_s_v4c
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRaq4QMtzoRSDOHAgVRLbqS1OqMuqPLYgRKUekCI_q4pusmp2D8vf4Y_icR50eUiIW5xMbMeZsWfG428AnvnM89xqngTbwyfMiDRRqghFfYAnL6W2Fv2Q0-Pi6IS9PeWnG_CyPwvT4kMMDjeUjDhfo4DPrb8i5Lae4c4kZqy9xoqgSaBG9OkndhSjMTtemAmCyEsM49nuw3iGV9cXo980zHWFNa44k5vwpe9rG2jydX-50Pvm2y8wjv_5Mdtwo9NEyauWdXZgw1W3YGva7bXfhu9jxNTt0mGRecThrBpSe3KODuHZqkanP0axElVZEib59ZteLYhekZk6q_CgJAl2fY3oHo6cz2JqpFAPaZYaHUENQX8w6R3BL8j80vWFWHsVVOv67GJlFAbzky7AvrkDJ5PXnw-Pki6lQ2KoEDSRhWKpl5lhmWYK5d_j6VejDnxqJZU6Fzw1zkhdOK5Nqp10Pmg1PFPcGpPRu7BZ1ZW7D8QEvjKFZqKglgkuVMqtD-afEIWgWe5G8Lz_t6Xp8M4x7cZF2ds9YdDLOOgjeDqQzluQjz8R7fYMUnZy3pTBIMsRrkjkI3gyPA4SioOtKlcvkSaTAs1ONoJ7LWMNrVAqo0UbOhvZ4-_Nl-MP03jx4N9JH8PWx_GkfP_m-N1DuJ5jNE4MXdyFzcXl0j0K6tRC70Wx-QGdvB2M
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Distribution+patterns+of+intramyocellular+and+extramyocellular+fat+by+magnetic+resonance+imaging+in+subjects+with+diabetes%2C+prediabetes+and+normoglycaemic+controls&rft.jtitle=Diabetes%2C+obesity+%26+metabolism&rft.au=Kiefer%2C+Lena+S.&rft.au=Fabian%2C+Jana&rft.au=Rospleszcz%2C+Susanne&rft.au=Lorbeer%2C+Roberto&rft.date=2021-08-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1462-8902&rft.eissn=1463-1326&rft.volume=23&rft.issue=8&rft.spage=1868&rft.epage=1878&rft_id=info:doi/10.1111%2Fdom.14413&rft.externalDBID=10.1111%252Fdom.14413&rft.externalDocID=DOM14413
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1462-8902&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1462-8902&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1462-8902&client=summon